Overview of CASP8 Plasmids

CASP8 (Caspase-8) Plasmids are essential tools in molecular biology and biomedical research, specifically in the study of apoptosis and cell signaling pathways. Caspase-8 is a cysteine-aspartic protease that plays a critical role in the extrinsic pathway of apoptosis, acting as an initiator caspase. The CASP8 gene encodes a protein that is involved in the activation of downstream effector caspases, leading to programmed cell death.

Content

CASP8 Plasmids: Technical Insights

  • Structure and Function:
    • Gene: CASP8 gene is located on chromosome 2q33-q34 and encodes a protein of approximately 55 kDa.
    • Protein Domains: The Caspase-8 protein contains two death effector domains (DEDs) at the N-terminus, which facilitate its interaction with other signaling molecules, and a catalytic domain at the C-terminus responsible for its protease activity.
    • Activation Mechanism: Caspase-8 is activated through dimerization and cleavage in response to signals from death receptors such as Fas (CD95) and TNF receptor (TNFR).
  • Applications:
    • Apoptosis Research: CASP8 plasmids are widely used to study the mechanisms of apoptosis. By overexpressing or silencing CASP8 in cells, researchers can investigate the pathways leading to cell death and identify potential therapeutic targets for diseases characterized by dysregulated apoptosis.
    • Cancer Studies: Aberrant regulation of Caspase-8 is implicated in various cancers. CASP8 plasmids are employed to understand its role in tumor progression and to develop strategies to restore its apoptotic function in cancer cells.
    • Drug Development: Screening for drugs that can modulate Caspase-8 activity is facilitated by using CASP8 plasmids in high-throughput assays.
  • Types of CASP8 Plasmids:
    • Overexpression Plasmids: These plasmids contain the full-length CASP8 cDNA under the control of a strong promoter, allowing for high levels of Caspase-8 expression in transfected cells.
    • shRNA/siRNA Plasmids: Designed to silence CASP8 expression, these plasmids express short hairpin RNA (shRNA) or small interfering RNA (siRNA) sequences that target CASP8 mRNA for degradation, effectively knocking down its expression.
    • Reporter Plasmids: These plasmids contain Caspase-8 responsive elements linked to a reporter gene, such as luciferase, enabling the monitoring of Caspase-8 activation in real-time.
  • Experimental Considerations:
    • Transfection Efficiency: The success of experiments using CASP8 plasmids relies on efficient delivery into target cells. Various transfection methods, including lipid-based transfection, electroporation, and viral transduction, can be optimized based on cell type and plasmid construct.
    • Controls: Proper experimental controls, such as empty vector plasmids and non-targeting shRNA plasmids, are crucial to validate the specificity and efficacy of CASP8 manipulation.
    • Validation: Post-transfection, the expression and activity of Caspase-8 should be validated using techniques such as Western blotting, qPCR, and activity assays to confirm the desired modification.
For Price Contact info@affigen.com 0.0 USD
For Price Contact info@affigen.com 0.0 USD
For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pCMV-EGFP-CASP8 (human) -2-Neo
CAT# AFG-GNC-9980
Size: 1 Unit
For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pCMV-CASP8 (human) -3×FLAG-Neo
CAT# AFG-GNC-9382
Size: 1 Unit
For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pCMV6-CASP8-3*FLAG
CAT# AFG-GNC-4482
Size: 1 Unit
For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pOTB7-CASP8
CAT# AFG-NVF-108046
Size: 2 μg
276.00 276.0 USD
AffiPLASMID® pEnCMV-FLAG-Casp8-SV40-Neo Plasmid
CAT# AFG-NVF-093910
Size: 2 μg
276.00 276.0 USD
276.00 276.0 USD
AffiPLASMID® pcDNA3.1-Flag-CASP8 Plasmid
CAT# AFG-NVF-077100
Size: 2 μg
283.60 283.6 USD